Neutrophil extracellular traps may play role in organ failure in cancer
the ONA take:
Neutrophils may play an important role in organ failure in patients with primary or metastatic tumors, according to research out of Uppsala University published in Cancer Research.
While the main function of neutrophil blood cells is to protect against infections, the presence of tumors in the body may fool immune cells into fighting non-existent infections through the formation of neutrophil extracellular traps (NETs).
In their mouse study, the researchers demonstrated that NETs that gathered in mice with cancer caused decreased functionality of blood vessels as well as inflammation of organs that were not affected by actual or metastatic tumor cells.
DNase treatment was used to restore vascular function in the kidneys and hearts of afflicted mice to those of non-tumor-carrying mice. In addition, it also suppressed inflammation.
“Our findings strongly suggest that NETs mediate the negative collateral effects of tumors on distal organs, but that this condition is reversible,” said Anna-Karin Olsson, senior lecturer at Uppsala University.
Neutrophils may play an important role in organ failure in patients with primary or metastatic tumors.
Sign Up for Free e-newsletters
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- Overall Survival Prolonged With HIPEC + Cytoreductive Surgery for Gastric Cancer
- Better Postoperative Outcomes With RAMIE for Esophageal Cancer
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|